Pharmacy & Biological Sciences
Category
BU Wins $20M for NSF Engineering Research Center
The recipient’s ultimate goal is to advance nano-bio-manufacturing methods that could lead to large-scale fabrication of functional heart tissue, which could replace diseased or damaged muscle after a heart attack.
FDA Moves To Guard Against Abuse Of ‘Orphan Drug’ Program
The FDA is changing the way it approves medicines known as “orphan drugs” after revelations that drugmakers may be abusing a law intended to help patients with rare diseases.
Institute for Biomedical Sciences Introduces Innovative Doctoral Program
GSU’s Institute for Biomedical Sciences has welcomed its first class into an innovative interdisciplinary program meant to cultivate the next generation of leaders in the biomedical sector.
NIH’s All of Us Research Program Expands National Network of Medical Centers
The program is a bold effort to gather data over time from more than 1M people living in the U.S., with the ultimate goal of accelerating research and improving health.
The Implications of the Opioid Lawsuits
Opioid manufacturers, drug distributors, and pharmacy chains continue to get hit with lawsuits alleging they fueled the nation’s opioid crisis through deceptive marketing and negligence.
Advocates Prepare for Rally for Medical Research
Advocates will descend upon Washington, D.C. on September 13th and 14th to discuss the economic and health impact of research supported by the NIH.
5 Researchers Share $500,000 Prize for Work on Gene Editing
The recipients of the annual Albany Medical Center Prize in Medicine and Biomedical Research are being recognized for their contributions related to the development of the tool, called CRISPR-Cas9.
South Carolina Sues Oxycontin Maker Purdue over Opioid Marketing
The lawsuit by South Carolina Attorney General Alan Wilson, filed in Richland County Court of Common Pleas in Columbia, accuses the company of the unfair and deceptive marketing of opioid painkillers.
What’s the Missing Link for STEM Diversity?
The problem isn’t new and it isn’t going away by itself. But it is getting more and more attention. Mainly due to the fact that a diverse science and engineering workforce is absolutely critical for innovation, entrepreneurism, and a competitive national economy.
NIH Accelerates the Use of Genomics in Clinical Care
The new grants will support the development of methods needed to integrate genome sequencing into the practice of medicine, improve the discovery and interpretation of genomic variants, and investigate the impact of genome sequencing on healthcare outcomes.